
Abbott’s Takedown Shakedown – an update
Following action from users, admins, healthcare staff and advocates, Abbott have responded on the takedown shenanigans. This seems to be a company statement that has […]
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Following action from users, admins, healthcare staff and advocates, Abbott have responded on the takedown shenanigans. This seems to be a company statement that has […]
Over the past 48 hours, numerous Facebook groups across Europe that were unaffiliated with Abbott but provided “User group” services to Freestyle Libre users received […]
Breaking news in the world of Diabetes tech today saw Medtronic and Abbott share news of a partnership to provide Abbott CGM technology to Medtronic […]
As I mentioned a couple of weeks ago, I received a number of Libre2 and Libre2 Plus devices to try. So far, I’ve only used […]
What impact does a botched rollout of an app update have on a CGM provider?
As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, […]
As a headline, this seems like a harsh statement to make. As an observation of the organisation and effectiveness of England’s healthcare model, perhaps less […]
It was only a little over a week ago that Abbott released their Libre Sense, offering up CGM for athletes without a medical approval, with […]
Whilst that’s a very poor nod to Shakespeare, Libre Sense is the question here. And that’s because they announced the launch of a “Glucose Sport […]
As many of us do going in to the new year, I made a decision to be more active, eat more healthily, etc. The usual […]
Copyright © 2025 | WordPress Theme by MH Themes